Antibiotics Flashcards

(75 cards)

1
Q

beta-lactam classes

A

penicillin
cephalosporin
carbapenem
monobactam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

penicillin subclasses

A

aminopenicillin (amoxicillin, ampicillin), anti-staphylococcal penicillin (methicillin, oxacillin, nafcillin), anti-pseudomonal penicillin (ticarcillin, piperacillin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

aminopenicillin examples

A

amoxicillin, ampicillin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

anti-staphylococcal penicillin examples

A

methicillin, nafcillin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

anti-pseudomonal penicillin examples

A

ticarcillin, piperacillin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

beta-lactam mechanism

A

binds to the penicillin binding proteins (PBPs) in the cell wall –> inhibits cross-linking of peptidoglycan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

beta-lactam resistance mechanisms

A

beta-lactamases
altered penicillin binding proteins (MRSA)- resistance transferred via MecA operon
decreased permeability (Pseudomonas)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

penicillin mechanism

A

binds to the penicillin binding proteins (PBPs) in the cell wall –> inhibits cross-linking of peptidoglycan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

penicillin resistance

A

beta-lactamases
altered penicillin binding proteins (MRSA)- resistance transferred via MecA operon
decreased permeability (Pseudomonas)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

cephalosporin examples

A
cefazolin (1st gen)
cefoxitin (2nd gen)
ceftriaxone (3rd gen)
gefepime (4th gen)
ceftaroline (MRSA active)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

monobactam examples

A

aztreonam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

cephalosporin mechanism

A

binds to the penicillin binding proteins (PBPs) in the cell wall –> inhibits cross-linking of peptidoglycan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

cephalosporin resistance mechanisms

A

altered penicillin binding proteins

beta lactamases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

monobactam mechanism

A

binds to the penicillin binding proteins (PBPs) in the cell wall –> inhibits cross-linking of peptidoglycan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

monobactam target

A

only have activity against gram negative aerobes (but does not include pseudomonas)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

carbapenem examples

A

imipenem, meropenem, ertapenem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

carbapenem mechanism

A

binds to the penicillin binding proteins (PBPs) in the cell wall –> inhibits cross-linking of peptidoglycan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

carbapenem resistance mechanism

A

decreased permeability of GNR outer membrane through loss of porins (i.e. Pseudomonas)
carbapenemases (broad spectrum beta lactamases)
carbapenem resistance enterobacteracae (CRE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

carbapenem target

A

everything except MRSA, enterococci and listeria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

vancomycin mechanism

A

interferes with cell wall synthesis by binding to d-alanine-d-alanine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

MLS group

A

macrolides, clindamycin (lincosamides), streptogramins (no longer used)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

MLS group mechanism

A

inhibits protein synthesis by binding to the ribosome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

macrolide examples

A

erythromycin, clarithromycin, azithromycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

macrolide mechanism

A

inhibit protein synthesis by binding to ribosome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
macrolide resistance mechanism
ribosomal methylation | drug efflux
26
clindamycin mechanism
inhibit protein synthesis by binding to ribosome
27
clindamycin resistance mechanism
ribosomal methylation
28
aminoglycoside examples
streptomycin, gentamicin, amikacin, tobramycin
29
aminoglycoside mechanism
inhibits protein synthesis by binding to ribosome
30
aminoglycoside resistance mechanism
enzymatic inactivation (i.e. sulfation, acetylation, phosphorylation)
31
tetracycline mechanism
inhibits protein synthesis by binding to ribosome
32
tetracycline resistance mechanism
altered ribosome | drug efflux
33
glycyclcycline example
tigecycline
34
glycyclcycline mechanism
inhibits protein synthesis by binding to ribosome
35
glycylcycline resistance mechanism
drug efflux
36
co-trimoxazole example
trimethoprim/sulfamethoxazole (TMP/SXT)
37
TMP/SXT mechanism
blocks biosynthesis of nucleic acids (targets folic acid formation)
38
TMP/SXT resistance mechanism
increased production of dihydrofolate reductase
39
fluoroquinolone examples
ciprofloxacin, levofloxacin, moxifloxacin
40
fluoroquinolone mechanism
inhibits DNA gyrase and topoisomerase
41
fluoroquinolone resistance mechanism
DNA gyrase/topoisomerase mutation | drug efflux
42
rifampin (rifamycin) mechanism
inhibits DNA dependent RNA polymerase (inhibits protein synthesis at the translation level)
43
rifampin (rifamycin) resistance mechanisms
mutations in the DNA dependent RNA polymerase
44
lipopeptide examples
daptomycin
45
lipopeptide mechanism
Ca2+ dependent increase in membrane permeability to potassium
46
oxazolidine examples
linezolid, tedizolid
47
oxazolidine mechanism
inhibits protein synthesis at level of ribosomal translation
48
polymyxin examples
polymyxin B, colistin
49
polymyxin mechanism
intercalates with LPS in gram negative membrane
50
cephalosporin target
gram negative bacteria and MRSA (ceftaroline)
51
ceftriaxone target
can cross the blood-brain barrier --> **use for meningitis
52
aminoglycoside target
gram negative only, no activity against anaerobes
53
fluoroquinolone benefit
very bioavailable
54
aminoglycoside consequence
**high toxicity to therapeutic ratio
55
polymyxin consequence
toxic
56
fidaxomicin target
only used to treat Clostridium difficile | nonabsorbable oral drug
57
rifampin use
always use in combination with another drug to protect rifampin
58
rifampin benefit
gets past biofilm layer
59
beta-lactam pharmacodynamics
time above MIC
60
aminoglycoside pharmacodynamics
peak MIC
61
fluoroquinolone pharmacodynamics
AUC/MIC
62
antibiotics used in synergy
ampicillin and aminoglycosides to treat enterococci
63
antifungals used in synergy
amphotericin B and flucytosine to treat cryptococcus
64
drugs that cross the blood-brain barrier
ceftriaxone (antibiotic), fluconazole (anti-fungal)
65
type 1 allergic reaction to beta-lactams
immediate hypersensitivity- IgE/mast cell mediated
66
type 2 allergic reaction to beta-lactams
innocent bystandard- adherence of a drug as a hapten to a cell, leads to hemolytic anemia
67
type 3 allergic reaction to beta-lactams
"Arthus" immune complex- serum sickness; fever, glomerulonephritis, arthritis, adenopathy
68
type 4 allergic reaction to beta-lactams
delayed hypersensitivity- T cell mediated, usually after 7-10 days of antibiotics; presents with a rash
69
antibiotics that target the cell wall
beta lactams (penicillin, cephalosporins, carbapenems, monobactam), vancomycin
70
antibiotics that bind the ribosome (to inhibit protein synthesis)
macrolides, clindamycin, aminoglycosides, tetracyclines, glycylcycline
71
antibiotics that target DNA gyrase and topoisomerase
fluoroquinolones
72
antibiotics that target DNA dependent RNA polymerase
rifampin
73
antibiotics that inhibit protein synthesis at the level of ribosomal translation
oxazolidine
74
antibiotics that increase membrane permeability
lipopeptides
75
antibiotics that intercalate with LPS
polymyxins